These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 13783849)

  • 1. Drug dangers and reactions.
    WEILERSTEIN RW
    Calif Med; 1961 Jan; 94(1):9-11. PubMed ID: 13783849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies.
    Chen B; Restaino J; Tippett E
    Cancer Treat Res; 2019; 171():47-59. PubMed ID: 30552656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administrative detention of drugs intended for human or animal use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 May; 79(103):30716-21. PubMed ID: 24873018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment.
    Gaylor DW; Bolger PM; Schwetz BA
    Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):391-4. PubMed ID: 9539036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of newly approved drugs: implications for prescribing.
    Temple RJ; Himmel MH
    JAMA; 2002 May; 287(17):2273-5. PubMed ID: 11980528
    [No Abstract]   [Full Text] [Related]  

  • 8. Generally Regarded As Safe.
    Novack GD
    Ocul Surf; 2017 Jan; 15(1):152-155. PubMed ID: 27871773
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and critique of the Institute of Medicine report "the future of drug safety".
    Benet LZ
    Clin Pharmacol Ther; 2007 Feb; 81(2):158-61. PubMed ID: 17259941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Drug Safety in Children - The Role of Real-World Data.
    McMahon AW; Dal Pan G
    N Engl J Med; 2018 Jun; 378(23):2155-2157. PubMed ID: 29874532
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
    Carrier MK
    Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729
    [No Abstract]   [Full Text] [Related]  

  • 13. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 14. Today's requirements in food, drug and chemical control.
    Osterberg RE
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():201-28. PubMed ID: 6880782
    [No Abstract]   [Full Text] [Related]  

  • 15. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.
    Rivera DR; Hartzema AG
    Ann Pharmacother; 2014 Mar; 48(3):369-79. PubMed ID: 24311725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-marketing surveillance of prescription drug safety: past, present, and future.
    Chen BK; Yang YT
    J Leg Med; 2013; 34(2):193-213. PubMed ID: 23980746
    [No Abstract]   [Full Text] [Related]  

  • 18. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unapproved drugs in the United States and the Food and Drug Administration.
    Nasr A; Lauterio TJ; Davis MW
    Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADVERSE DRUG REACTION REPORTING AND THE RELATED ESTABLISHMENT OF A REGISTRY OF TISSUE REACTIONS TO DRUGS.
    WESTON JK
    Med Ann Dist Columbia; 1965 Aug; 34():380-2. PubMed ID: 14338452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.